KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Treasury Shares (2016 - 2026)

AbbVie has reported Treasury Shares over the past 13 years, most recently at $9.1 billion for Q4 2025.

  • Quarterly Treasury Shares rose 11.52% to $9.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 billion through Dec 2025, up 11.52% year-over-year, with the annual reading at $9.1 billion for FY2025, 11.52% up from the prior year.
  • Treasury Shares was $3.0 million for Q4 2025 at AbbVie, down from $70.8 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $70.8 million in Q2 2025 and troughed at $3.0 million in Q4 2025.
  • The 5-year median for Treasury Shares is $8.0 million (2021), against an average of $14.6 million.
  • The largest YoY upside for Treasury Shares was 54.34% in 2021 against a maximum downside of 87.98% in 2021.
  • A 5-year view of Treasury Shares shows it stood at $3.1 billion in 2021, then soared by 46.17% to $4.6 billion in 2022, then surged by 42.21% to $6.5 billion in 2023, then increased by 25.53% to $8.2 billion in 2024, then rose by 11.52% to $9.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Treasury Shares are $9.1 billion (Q4 2025), $9.1 billion (Q3 2025), and $9.1 billion (Q2 2025).